David Burden

1.1k total citations
17 papers, 528 citations indexed

About

David Burden is a scholar working on Immunology, Physiology and Dermatology. According to data from OpenAlex, David Burden has authored 17 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 6 papers in Physiology and 5 papers in Dermatology. Recurrent topics in David Burden's work include Psoriasis: Treatment and Pathogenesis (10 papers), Dermatology and Skin Diseases (5 papers) and Asthma and respiratory diseases (5 papers). David Burden is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (10 papers), Dermatology and Skin Diseases (5 papers) and Asthma and respiratory diseases (5 papers). David Burden collaborates with scholars based in United Kingdom, Germany and Switzerland. David Burden's co-authors include Elwood S. Buffa, Joyce Leman, Juliet N. Barker, Francesca Capon, Richard C. Trembath, Michael H. Allen, Colin Veal, Julie Evans, David M. Tillman and Emma Heath and has published in prestigious journals such as The American Journal of Human Genetics, American Journal Of Pathology and Journal of Investigative Dermatology.

In The Last Decade

David Burden

14 papers receiving 492 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Burden United Kingdom	8	184	145	119	107	65	17	528
L.W.G. Strijbosch Netherlands	15	153 0.8×	52 0.4×	224 1.9×	9 0.1×	267 4.1×	36	682
Kazuyoshi� Ishii Japan	16	203 1.1×	99 0.7×	129 1.1×	9 0.1×	29 0.4×	103	874
J Sun United States	9	51 0.3×	46 0.3×	74 0.6×	8 0.1×	48 0.7×	16	358
Pierre Lemaire France	14	27 0.1×	76 0.5×	12 0.1×	39 0.4×	37 0.6×	45	450
Hidekazu Tsuji Japan	7	161 0.9×	9 0.1×	31 0.3×	96 0.9×	32 0.5×	27	427
Thomas Casey Finland	13	55 0.3×	34 0.2×	21 0.2×	3 0.0×	63 1.0×	27	486
Runnan Li Taiwan	4	46 0.3×	39 0.3×	28 0.2×	4 0.0×	29 0.4×	8	433
Ali Ibrahim Sevınç Türkiye	11	6 0.0×	72 0.5×	26 0.2×	71 0.7×	16 0.2×	51	465
Samuel T. Waters United States	13	276 1.5×	11 0.1×	21 0.2×	4 0.0×	19 0.3×	21	616

Countries citing papers authored by David Burden

Since Specialization

Citations

This map shows the geographic impact of David Burden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Burden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Burden more than expected).

Fields of papers citing papers by David Burden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Burden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Burden. The network helps show where David Burden may publish in the future.

Co-authorship network of co-authors of David Burden

This figure shows the co-authorship network connecting the top 25 collaborators of David Burden. A scholar is included among the top collaborators of David Burden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Burden. David Burden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Warren, Richard B., David Burden, Siew Eng Choon, et al.. (2023). Effect of Subcutaneous Spesolimab on the Prevention of Generalized Pustular Psoriasis Flares Over 48 weeks: Subgroup Analyses from the Effisayil 2 Trial. SKIN The Journal of Cutaneous Medicine. 7(6). s245–s245. 2 indexed citations

Burden, David, Yukari Okubo, Min Zheng, et al.. (2023). Efficacy of spesolimab for the treatment of GPP flares across prespecified patient subgroups in the Effisayil 1 study. SKIN The Journal of Cutaneous Medicine. 7(2). s121–s121.

Cro, Suzie, Prakash A. Patel, Juliet N. Barker, et al.. (2020). A randomised placebo controlled trial of anakinra for treating pustular psoriasis: statistical analysis plan for stage two of the APRICOT trial. Trials. 21(1). 158–158. 5 indexed citations

Cornelius, Victoria, Suzie Cro, Juliet N. Barker, et al.. (2018). A small population, randomised, placebo-controlled trial to determine the efficacy of anakinra in the treatment of pustular psoriasis: study protocol for the APRICOT trial. Trials. 19(1). 465–465. 12 indexed citations

Warren, Richard B., A.Y. Finlay, Juliet N. Barker, et al.. (2018). PSS7 - QUALITY OF LIFE IMPROVEMENTS IN PSORIASIS WITH SECUKINUMAB IN A DIFFICULT TO TREAT POPULATION OF ANTI-TNF ALPHA FAILURE PATIENTS FROM THE UK AND REPUBLIC OF IRELAND. Value in Health. 21. S423–S423. 1 indexed citations

Warren, Richard B., David Burden, Barbara Tomenson, et al.. (2016). 024 Psoriasis Stratification to Optimise Relevant Therapy (PSORT): Clinical and demographic predictors of biologic response for psoriasis. Journal of Investigative Dermatology. 136(9). S164–S164. 1 indexed citations

Navarini, Alexander A., et al.. (2016). 442 European consensus statement on phenotypes of pustular psoriasis. Journal of Investigative Dermatology. 136(9). S236–S236. 3 indexed citations

Baldwin, Helen, David Burden, Iain B. McInnes, et al.. (2012). Elevated Expression of the Chemokine-Scavenging Receptor D6 Is Associated with Impaired Lesion Development in Psoriasis. American Journal Of Pathology. 181(4). 1158–1164. 37 indexed citations

Capon, Francesca, Paola Di Meglio, Michael Allen, et al.. (2007). The R381Q variant of the interleukin-23 receptor gene (IL23R) confers protection against psoriasis vulgaris. British Journal of Dermatology. 156(5). 1099–1099.

10.

Allen, M H, Yan Zhao, Hong Liao, et al.. (2007). Psoriasis shows no association with filaggrin-null alleles. British Journal of Dermatology. 156(5). 1111–1111.

11.

Zhao, Yiwei, Ana Terron-Kwiatkowski, Haihui Liao, et al.. (2007). Filaggrin Null Alleles Are Not Associated with Psoriasis. Journal of Investigative Dermatology. 127(8). 1878–1882. 36 indexed citations

12.

Stover, Cordula, Sharon Barrett, Nicholas J. Lynch, et al.. (2005). Functional MASP2 single nucleotide polymorphism plays no role in psoriasis. British Journal of Dermatology. 152(6). 1313–1315. 7 indexed citations

13.

Capon, Francesca, et al.. (2002). Family-based analysis using a dense single nucleotide polymorphism based map defines genetic variation at PSORS1, the major psoriasis susceptibility locus.. British Journal of Dermatology. 147(5). 1 indexed citations

14.

Veal, Colin, Francesca Capon, Michael H. Allen, et al.. (2002). Family-Based Analysis Using a Dense Single-Nucleotide Polymorphism–Based Map Defines Genetic Variation at PSORS1, the Major Psoriasis-Susceptibility Locus. The American Journal of Human Genetics. 71(3). 554–564. 117 indexed citations

15.

Leman, Joyce & David Burden. (2001). Psoriasis in Children. Pediatric Drugs. 3(9). 673–680. 30 indexed citations

16.

Burden, David & Elwood S. Buffa. (1969). Production-Inventory Systems: Planning and Control. OR. 20(2). 282–282. 67 indexed citations

17.

Burden, David. (1969). Production-Inventory Systems: Planning and Control. Journal of the Operational Research Society. 20(2). 282–283. 209 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact